| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer | Chief Operating Officer
2 companies
Lynne Marie Laube is Director at CDLX, with reported holdings spanning 2 companies. The disclosed holdings are worth an estimated $1.2M at current prices.
Our model assigns Lynne Marie Laube a strong insider score of 79/100, based on 15 past trades. Over a 12-month horizon, 86.7% of those trades were profitable, with an average 12-month return of +45.1%.
Lynne Marie Laube's largest disclosed position is in CDLX as Director, worth about $1.2M. The CDLX filings lean toward selling, a net 511,683 shares.
Lynne Marie Laube has 64 Form 4 filings on record from February 2018 to May 2026, across 2 companies: Director at NerdWallet (NRDS), 2022–2026; Director at Cardlytics (CDLX), 2018–2022.
The 224 reported transactions were 170 open-market sales, 32 option exercises, 11 option or other derivative awards and 6 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 44 sales worth about $25.0M.
The largest open-market sale was 200,000 shares of CDLX at an average $32.30 on September 13, 2019, about $6.5M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2022 | CDLX Cardlytics, Inc. | Director | Sell | 4 | $3.93 | $15.72 | - | +89.5% | +235.5% | |
| Nov 8, 2022 | CDLX Cardlytics, Inc. | Director | Sell | 6,782 | $4.30 | $29,180.21 | -2.1% | +89.5% | +235.5% | |
| Aug 5, 2022 | CDLX Cardlytics, Inc. | Chief Executive Officer | Sell | 6,612 | $15.19 | $100,436.28 | -2.1% | -62.6% | -6.0% | |
| May 5, 2022 | CDLX Cardlytics, Inc. | Chief Executive Officer | Sell | 17,973 | $33.60 | $603,892.80 | -4.8% | -53.0% | -82.4% | |
| Dec 10, 2021 | CDLX Cardlytics, Inc. | Chief Executive Officer | Sale+OE | 13,076 | $68.34 | $893,619.44 | -3.7% | -22.2% | -92.5% | |
| Nov 5, 2021 | CDLX Cardlytics, Inc. | Chief Executive Officer | Sell | 12,990 | $90.58 | $1,176,581.57 | -3.9% | -29.8% | -94.9% | |
| Jul 15, 2021 | CDLX Cardlytics, Inc. | Chief Executive Officer | Sale+OE | 5,514 | $123.84 | $682,872.66 | -1.8% | -32.9% | -89.0% | |
| Jun 4, 2021 | CDLX Cardlytics, Inc. | Chief Executive Officer | Sale+OE | 7,314 | $101.68 | $743,655.35 | -2.3% | -2.0% | -71.3% | |
| May 7, 2021 | CDLX Cardlytics, Inc. | Chief Executive Officer | Sell | 9,053 | $102.03 | $923,681.72 | -2.9% | -11.9% | -69.0% | |
| Apr 13, 2021 | CDLX Cardlytics, Inc. | Chief Executive Officer | Sale+OE | 4,278 | $108.02 | $462,103.49 | -1.3% | +17.5% | -54.1% |